Compare AFYA & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFYA | GSBD |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Finance: Consumer Services |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.1B |
| IPO Year | 2019 | N/A |
| Metric | AFYA | GSBD |
|---|---|---|
| Price | $14.44 | $9.93 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $18.10 | $9.00 |
| AVG Volume (30 Days) | 79.8K | ★ 1.3M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | 1.60% | ★ 12.88% |
| EPS Growth | 25.39 | ★ 69.72 |
| EPS | ★ 1.50 | 1.14 |
| Revenue | ★ $681,742,784.00 | $383,307,000.00 |
| Revenue This Year | $14.61 | N/A |
| Revenue Next Year | $8.34 | N/A |
| P/E Ratio | $9.64 | ★ $8.70 |
| Revenue Growth | ★ 14.07 | N/A |
| 52 Week Low | $13.47 | $9.35 |
| 52 Week High | $19.90 | $13.45 |
| Indicator | AFYA | GSBD |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 51.29 |
| Support Level | $14.15 | $9.90 |
| Resistance Level | $15.43 | $10.15 |
| Average True Range (ATR) | 0.32 | 0.15 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 27.45 | 55.82 |
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests primarily in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.